Shifting Treatment Strategies to Prevent Early Relapse of Locally Advanced Rectal Cancer After Preoperative Chemoradiotherapy.
作者信息
Park Eun Jung
机构信息
Division of Colon and Rectal Surgery, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
出版信息
Ann Coloproctol. 2020 Dec;36(6):357-358. doi: 10.3393/ac.2020.11.21. Epub 2020 Dec 31.
Abstract
摘要
相似文献
1
Shifting Treatment Strategies to Prevent Early Relapse of Locally Advanced Rectal Cancer After Preoperative Chemoradiotherapy.转变治疗策略以预防术前放化疗后局部晚期直肠癌的早期复发
Ann Coloproctol. 2020 Dec;36(6):357-358. doi: 10.3393/ac.2020.11.21. Epub 2020 Dec 31.
2
The impact of tumor regression grade on long-term survival in locally advanced rectal cancer treated with preoperative chemoradiotherapy.肿瘤退缩分级对术前放化疗治疗的局部晚期直肠癌长期生存的影响。
J Oncol Pharm Pract. 2020 Oct;26(7):1611-1620. doi: 10.1177/1078155219900944. Epub 2020 Feb 11.
3
Relationships between SMAD3 expression and preoperative fluoropyrimidine-based chemoradiotherapy response in locally advanced rectal cancer patients.局部晚期直肠癌患者中SMAD3表达与术前氟嘧啶类药物同步放化疗反应的关系
World J Surg. 2015 May;39(5):1257-67. doi: 10.1007/s00268-014-2917-0.
4
[Genetic variations in MLH3 and MSH2 genes are associated with the sensitivity and prognosis in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy].[MLH3和MSH2基因的遗传变异与接受术前放化疗的局部晚期直肠癌患者的敏感性和预后相关]
Zhonghua Zhong Liu Za Zhi. 2018 Jun 23;40(6):433-440. doi: 10.3760/cma.j.issn.0253-3766.2018.06.007.
5
Impact of preoperative chemoradiotherapy using concurrent S-1 and CPT-11 on long-term clinical outcomes in locally advanced rectal cancer.术前同步使用S-1和CPT-11进行放化疗对局部晚期直肠癌长期临床结局的影响。
World J Gastrointest Oncol. 2020 Mar 15;12(3):311-322. doi: 10.4251/wjgo.v12.i3.311.
6
MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer.微小RNA-21可预测局部晚期直肠癌对术前放化疗的反应。
Int J Colorectal Dis. 2015 Jul;30(7):899-906. doi: 10.1007/s00384-015-2231-9. Epub 2015 May 8.
7
Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer.术前放化疗后选择性侧方盆腔淋巴结清扫术治疗局部进展期直肠癌的疗效和预后因素。
Int J Colorectal Dis. 2018 Apr;33(4):367-374. doi: 10.1007/s00384-018-2974-1. Epub 2018 Feb 13.
8
F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer.F-FDG PET/CT 是贝伐珠单抗术前放化疗治疗高危局部进展期直肠癌后预测病理肿瘤反应和生存的早期指标。
J Nucl Med. 2019 Nov;60(11):1560-1568. doi: 10.2967/jnumed.118.222604. Epub 2019 Mar 15.
9
Timely tumor response analysis after preoperative chemoradiotherapy and curative surgery in locally advanced rectal cancer: A multi-institutional study for optimal surgical timing in rectal cancer.局部晚期直肠癌术前放化疗及根治性手术后的及时肿瘤反应分析：一项关于直肠癌最佳手术时机的多机构研究
Radiother Oncol. 2016 Jun;119(3):512-8. doi: 10.1016/j.radonc.2016.03.017. Epub 2016 Apr 19.
10
A phase III randomized controlled trial comparing surgery plus adjuvant chemotherapy with preoperative chemoradiotherapy followed by surgery plus adjuvant chemotherapy for locally recurrent rectal cancer: Japan Clinical Oncology Group study JCOG1801 (RC-SURVIVE study).一项比较手术加辅助化疗与术前放化疗后手术加辅助化疗治疗局部复发性直肠癌的 III 期随机对照临床试验：日本临床肿瘤学组研究 JCOG1801（RC-SURVIVE 研究）。
Jpn J Clin Oncol. 2020 Aug 4;50(8):953-957. doi: 10.1093/jjco/hyaa058.
引用本文的文献
1
Nuclear Factor Erythroid 2-Related Factor 2/Kelch-Like ECH-Associated Protein 1 as a Predictor of Prognosis and Radiotherapy Resistance in Patients With Locally Advanced Rectal Cancer: A Prospective Analysis.核因子红细胞 2 相关因子 2/kelch 样 ECH 相关蛋白 1 作为局部晚期直肠癌患者预后和放疗抵抗的预测因子：一项前瞻性分析。
J Korean Med Sci. 2023 Jul 3;38(26):e200. doi: 10.3346/jkms.2023.38.e200.
2
Surgical safety in the COVID-19 era: present and future considerations.COVID-19 时代的手术安全：当前与未来的考量
Ann Surg Treat Res. 2022 Jun;102(6):295-305. doi: 10.4174/astr.2022.102.6.295. Epub 2022 Jun 7.
本文引用的文献
1
Early recurrence after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: Characteristics and risk factors.局部进展期直肠癌新辅助放化疗后早期复发：特征和危险因素。
Asian J Surg. 2021 Jan;44(1):298-302. doi: 10.1016/j.asjsur.2020.07.014. Epub 2020 Jul 25.
2
Beware of Early Relapse in Rectal Cancer Patients Treated With Preoperative Chemoradiotherapy.警惕接受术前放化疗的直肠癌患者早期复发
Ann Coloproctol. 2020 Dec;36(6):382-389. doi: 10.3393/ac.2020.06.11. Epub 2020 Jun 17.
3
Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer.复发与挽救性手术对直肠癌多学科治疗后生存的影响
J Clin Oncol. 2017 Aug 10;35(23):2631-2638. doi: 10.1200/JCO.2016.72.1464. Epub 2017 Jun 28.
4
Total neoadjuvant therapy for rectal cancer: An emerging option.直肠癌的新辅助治疗：一种新兴的选择。
Cancer. 2017 May 1;123(9):1497-1506. doi: 10.1002/cncr.30600. Epub 2017 Mar 10.
5
Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.术前放化疗可提高局部晚期直肠癌的无局部复发生存率。
J BUON. 2013 Apr-Jun;18(2):385-90.
6
Early recurrence in patients undergoing curative surgery for colorectal cancer: is it a predictor for poor overall survival?结直肠癌根治性手术后早期复发：是否是总体生存不良的预测因素？
Int J Colorectal Dis. 2013 Aug;28(8):1143-9. doi: 10.1007/s00384-013-1675-z. Epub 2013 Mar 16.
7
Pulmonary recurrence predominates after combined modality therapy for rectal cancer: an original retrospective study.直肠癌综合治疗后肺复发为主：一项原创回顾性研究。
Ann Surg. 2012 Jul;256(1):111-6. doi: 10.1097/SLA.0b013e31825b3a2b.
8
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.奥沙利铂联合每周大剂量氟尿嘧啶和亚叶酸作为II期和III期结肠癌的手术辅助化疗：NSABP C-07研究结果
J Clin Oncol. 2007 Jun 1;25(16):2198-204. doi: 10.1200/JCO.2006.08.2974. Epub 2007 Apr 30.
9
Preoperative versus postoperative chemoradiotherapy for rectal cancer.直肠癌术前与术后放化疗对比
N Engl J Med. 2004 Oct 21;351(17):1731-40. doi: 10.1056/NEJMoa040694.
10
Micrometastases and survival in stage II colorectal cancer.II期结直肠癌中的微转移与生存情况
N Engl J Med. 1998 Jul 23;339(4):223-8. doi: 10.1056/NEJM199807233390403.
Zotero 插件